1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy

被引：0
|
作者：
Ian Y. Wong
Xuan Shi
Rita Gangwani
Paul Zhao
Lawrence P. Iu
Qing Li
Alex Ng
Xiaoxin Li
机构：
[1] The University of Hong Kong,Department of Ophthalmology, LKS Faculty of Medicine
[2] Peking University People’s Hospital,Department of Ophthalmology
[3] National University Hospital,Department of Ophthalmology
来源：
BMC Ophthalmology | / 15卷
关键词：
Age related macular degeneration; Half-dose; Half-fluence; Photodynamic therapy; Polypoidal choroidal vasculopathy; Ranibizumab; Verteporfin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy
    Kurashige, Yumiko
    Otani, Atsushi
    Sasahara, Manabu
    Yodoi, Yuko
    Tamura, Hiroshi
    Tsuikawa, Akitaka
    Yoshimura, Nagahisa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 146 (04) : 513 - 519
  • [32] Factors associated with retreatment after photodynamic therapy combined with intravitreal ranibizumab for polypoidal choroidal vasculopathy
    Kikushima, Wataru
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Tanabe, Naohiko
    Yoneyama, Seigo
    Iijima, Hiroyuki
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [33] Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab
    Hata, Masayuki
    Tsujikawa, Akitaka
    Miyake, Masahiro
    Yamashiro, Kenji
    Ooto, Sotaro
    Oishi, Akio
    Nakata, Isao
    Takahashi, Ayako
    Yoshimura, Nagahisa
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (02) : 189 - 197
  • [34] Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab
    Masayuki Hata
    Akitaka Tsujikawa
    Masahiro Miyake
    Kenji Yamashiro
    Sotaro Ooto
    Akio Oishi
    Isao Nakata
    Ayako Takahashi
    Nagahisa Yoshimura
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 189 - 197
  • [35] Long-term results of photodynamic therapy or ranibizumab for polypoidal choroidal vasculopathy in LAPTOP study
    Miyamoto, Noriko
    Mandai, Michiko
    Oishi, Akio
    Nakai, Shunichiro
    Honda, Shigeru
    Hirashima, Takafumi
    Oh, Hideyasu
    Matsumoto, Yoshiko
    Uenishi, Mamoru
    Kurimoto, Yasuo
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (06) : 844 - 848
  • [36] CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Tanabe, Naohiko
    Kikushima, Wataru
    Kume, Atsuki
    Iijima, Hiroyuki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1866 - 1872
  • [37] Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year
    Kokame, Gregg T.
    Yeung, Ling
    Teramoto, Kyla
    Lai, James C.
    Wee, Raymond
    OPHTHALMOLOGICA, 2014, 231 (02) : 94 - 102
  • [38] Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
    Mori, Ryusaburo
    Yuzawa, Mitsuko
    Akaza, Eriko
    Haruyama, Miho
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (04) : 365 - 371
  • [39] Five-year results of ICG-Guided Photodynamic Therapy combined with intravitreal Ranibizumab for juxtapapillary polypoidal choroidal vasculopathy with macular involvement
    Petropoulos, I. K.
    Matter, M. A.
    Desmangles, P. M.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [40] Photodynamic therapy for polypoidal choroidal vasculopathy
    Nowak-Sliwinska, Patrycja
    van den Bergh, Hubert
    Sickenberg, Michel
    Koh, Adrian H. C.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2013, 37 : 182 - 199
12345